肿瘤断裂负荷是结直肠癌基因组不稳定的生物学相关特征并具有预后价值
研究提出肿瘤断裂负荷(TBL)作为基因组不稳定的新量化指标,定义为SCNA相关结构变异之和。在85例II-III期MSS结直肠癌中高TBL与疾病复发相关(HR 6.1,p=0.007),并在两个独立验证系列中得以验证(HR 4.1,p=0.012;HR 2.4,p=0.01)。
要点
- TBL与肿瘤突变负荷及基因组改变分数相关性差,是独立的基因组不稳定特征。
- RNA分类器区分TBL高/低癌症准确率高(AUC 0.88,p<0.01)。
- 高TBL与II-III期MSS结直肠癌疾病复发相关,并在两个独立验证系列中验证。
核心结论
- TBL是非转移性MSS结直肠癌患者的预后生物标志物,在常规分子诊断中具有较大应用潜力。
研究设计与样本
- 从癌症基因组图谱和两项独立结直肠癌研究获取无病生存与SCNA数据。
- TBL定义为SCNA相关结构变异之和。
- 使用MSS结直肠癌样本的RNA基因表达数据训练基于RNA的TBL分类器。
- 使用二分类DNA-based TBL数据进行生存分析。
主要发现
- TBL在结直肠癌中变异大,与肿瘤突变负荷及基因组改变分数相关性差。
- RNA分类器区分TBL高与TBL低癌症的AUC为0.88(p<0.01)。
- 在癌症基因组图谱85例II-III期MSS结直肠癌中,高TBL与疾病复发相关(HR 6.1;p=0.007)。
- 在57例未经治疗的II-III期MSS结直肠癌验证系列中,高TBL与疾病复发相关(HR 4.1;p=0.012)。
- 在74例未经治疗的II期MSS结直肠癌验证系列中,高TBL与疾病复发相关(HR 2.4;p=0.01)。
关键数值与推荐
- TBL定义为SCNA相关结构变异之和。
- RNA-based TBL分类器区分TBL高与TBL低的AUC为0.88(p<0.01)。
- 高TBL与疾病复发关联的HR在癌症基因组图谱85例II-III期MSS结直肠癌中为6.1(p=0.007)。
- 高TBL与疾病复发关联的HR在57例未经治疗II-III期MSS结直肠癌验证系列中为4.1(p=0.012)。
- 高TBL与疾病复发关联的HR在74例未经治疗II期MSS结直肠癌验证系列中为2.4(p=0.01)。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Clinically implemented prognostic biomarkers are lacking for the 80% of colorectal cancers (CRCs) that exhibit chromosomal instability (CIN). CIN is characterised by chromosome segregation errors and double-strand break repair defects that lead to somatic copy number aberrations (SCNAs) and chromosomal rearrangement-associated structural variants (SVs), respectively. We hypothesise that the number of SVs is a distinct feature of genomic instability and defined a new measure to quantify SVs: the tumour break load (TBL). The present study aimed to characterise the biological impact and clinical relevance of TBL in CRC. METHODS: Disease-free survival and SCNA data were obtained from The Cancer Genome Atlas and two independent CRC studies. TBL was defined as the sum of SCNA-associated SVs. RNA gene expression data of microsatellite stable (MSS) CRC samples were used to train an RNA-based TBL classifier. Dichotomised DNA-based TBL data were used for survival analysis. RESULTS: TBL shows large variation in CRC with poor correlation to tumour mutational burden and fraction of genome altered. TBL impact on tumour biology was illustrated by the high accuracy of classifying cancers in TBL-high and TBL-low (area under the receiver operating characteristic curve [AUC]: 0.88; p < 0.01). High TBL was associated with disease recurrence in 85 stages II-III MSS CRCs from The Cancer Genome Atlas (hazard ratio [HR]: 6.1; p = 0.007) and in two independent validation series of 57 untreated stages II-III (HR: 4.1; p = 0.012) and 74 untreated stage II MSS CRCs (HR: 2.4; p = 0.01). CONCLUSION: TBL is a prognostic biomarker in patients with non-metastatic MSS CRC with great potential to be implemented in routine molecular diagnostics.
引用
- Lakbir S, Lahoz S, Cuatrecasas M, et al. Tumour break load is a biologically relevant feature of genomic instability with prognostic value in colorectal cancer. Eur J Cancer. 2022. PMID: 36334560. doi:10.1016/j.ejca.2022.09.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。